Skip to main content
. 2018 Sep 4;10:3237–3243. doi: 10.2147/CMAR.S169741

Table 1.

Baseline characteristics of papillary thyroid microcarcinoma patients stratified by the status of metastatic central lymph nodes

Characteristics The status of metastatic central lymph nodes
P-value
Positive Negative
Total 281 (41.8%) 392 (58.2%)
Tumor size (mm) 7.11±1.90 6.44±1.81 <0.001
 ≤5 (n, %) 68 (24.2%) 123 (31.4%) 0.042
 >5 (n, %) 213 (75.8%) 269 (68.6%)
Age at diagnosis (years) 46.37±10.44 47.58±10.44 0.14
 <45 (n, %) 121 (43.1%) 152 (38.8%) 0.264
 ≥45 (n, %) 160 (56.9%) 240 (61.2%)
Gender 0.13
 Male (n, %) 82 (29.2%) 94 (24.0%)
 Female (n, %) 199 (70.8%) 298 (76.0%)
BRAF mutation <0.001
 Yes (n, %) 243 (86.5%) 294 (75.0%)
 No (n, %) 38 (13.5%) 98 (25.0%)
Tumor location <0.001
 Lower (n, %) 78 (27.8%) 61 (15.6%)
 Upper/middle/isthmus (n, %) 203 (72.2%) 331 (84.4%)
Margin 0.002
 Well defined (n, %) 167 (59.4%) 278 (70.9%)
 Not well defined (n, %) 114 (40.6%) 114 (29.1%)
Contact of >25% with the adjacent capsule <0.001
 Yes (n, %) 159 (56.6%) 55 (15.2%)
 No (n, %) 122 (43.4%) 337 (84.8%)
Display of enlarged lymph nodes <0.001
 Present (n, %) 157 (55.9%) 127 (32.4%)
 Absent (n, %) 124 (44.1%) 265 (67.6%)
No. of nodules 0.117
 Single (n, %) 221 (78.6%) 327 (83.4%)
 Multiple (n, %) 60 (21.4%) 65 (16.6%)
Hashimoto’s thyroiditis 0.262
 Yes (n, %) 57 (20.3%) 95 (24.2%)
 No (n, %) 224 (79.7%) 297 (75.8%)
Calcification 0.001
 Present (n, %) 175 (62.2%) 194 (49.5%)
 Absent (n, %) 106 (37.8%) 198 (50.5%)
Shape 0.659
 Regular (n, %) 239 (85.1%) 337 (86.0%)
 Irregular (n, %) 42 (14.9%) 55 (14.0%)
Intact capsule 0.480
 Yes (n, %) 152 (54.1%) 223 (56.9%)
 No (n, %) 129 (45.9%) 169 (43.1%)
Composition 0.793
 Solid (n, %) 274 (97.5%) 384 (98.0%)
 Cystic or mixed (n, %) 7 (2.5%) 8 (2.0%)
Vascularization 0.506
 Present (n, %) 14 (5.0%) 25 (6.4%)
 Absent (n, %) 267 (95.0%) 367 (93.6%)